Evidence map›Paper›PMID 40296016›Full record

ArticleBMC ophthalmology2025

Evaluating the outcomes of inferonasal ahmed valve implantation using the double scleral tunnel technique in refractory glaucoma.

Mahmut Asfuroglu, Cenk Zeki Fikret

Abstract readComparative Study
In one paragraph

Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mahmut AsfurogluDepartment of Ophthalmology, Ankara Bilkent City Hospital, Ankara, Türkiye. drmaasfur@hotmail.com.ORCID http://orcid.org/0000-0003-2652-1085
Cenk Zeki FikretDepartment of Ophthalmology, Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-9154-9829

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate the efficacy and safety of inferonasal quadrant (IN) Ahmed Valve implantation (AVI) using the double scleral tunnel technique in patients who had previously failed glaucoma surgery.

methodsThis retrospective comparative study included data from 69 patients diagnosed with refractory glaucoma who were followed in a tertiary referral hospital. The IN-AVI group included 35 patients who underwent IN-AVI after failed trabeculectomy or superotemporal quadrant (ST) AVI, and the ST-AVI group included 34 patients who underwent primary ST-AVI. The primary outcome was to analyse the surgical success rate, the secondary outcome was to compare the intraocular pressure (IOP) reduction in the IN-AVI and ST-AVI groups at 1-year postoperatively.

resultsSignificant reduction in IOP was observed after IN-AVI at 1-year postoperatively (p < 0.001). The overall success rate was 88.6%. IN-AVI after failed trabeculectomy didn't differ from primary ST-AVI in terms of IOP reduction. IN-AVI after failed ST-AVI showed a lower IOP reduction compared to primary ST-AVI (p = 0.003). No tube exposure was observed at 1-year postoperatively using the double scleral tunnel technique.

conclusionsIn patients with refractory glaucoma, IN-AVI after failed trabeculectomy was as effective as the primary ST-AVI. Although IN-AVI after failed ST-AVI was effective in reducing IOP, it was significantly less effective than the primary ST-AVI. The prior failure of a trabeculectomy had no impact on the success of AVI. Conversely, a second AVI was less efficacious than the primary AVI.

Indexed as

GlaucomaGlaucoma Drainage ImplantsIntraocular PressureProsthesis ImplantationScleraAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesTrabeculectomyTreatment OutcomeVisual AcuityAhmed Glaucoma ValveDouble Scleral Tunnel TechniqueRefractory glaucoma

Identifiers

PMID40296016
PMCPMC12039285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.